Quest Diagnostics (DGX)
Quest Diagnostics Max Pain By Strike
DGX trades at $182.79, 4.5% above the near-term max pain of $175 expiring Sep 19, 2025 (30 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($135-$180), reflecting growing call interest at higher strikes. Key magnetic zone at 170 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Quest Diagnostics Max Pain By Expiry
Max pain for DGX shows an upward trend from 135 to 180, suggesting bullish positioning in longer-dated options. The 27% spread signals divergent expectations across timeframes. Most levels below 182.79 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 175 | -7.79 (-4.26%) |
| Oct 17, 2025 | 180 | -2.79 (-1.53%) |
| Nov 21, 2025 | 170 | -12.79 (-7.00%) |
| Dec 19, 2025 | 160 | -22.79 (-12.47%) |
| Jan 16, 2026 | 165 | -17.79 (-9.73%) |
| Feb 20, 2026 | 170 | -12.79 (-7.00%) |
| Mar 20, 2026 | 135 | -47.79 (-26.14%) |